SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-22-000029
Filing Date
2022-05-13
Accepted
2022-05-13 16:06:05
Documents
13
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20220510.htm   iXBRL 8-K 39681
2 EX-99.1 exhibit991q12022earningsre.htm EX-99.1 49379
  Complete submission text file 0001587221-22-000029.txt   232245

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20220510.xsd EX-101.SCH 1939
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20220510_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20220510_pre.xml EX-101.PRE 12666
7 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20220510_htm.xml XML 10823
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 22922684
SIC: 2834 Pharmaceutical Preparations